Esmolol
Top View
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Information for the Patient ESMOLOL HYDROCHLORIDE 2500 Mg
- 2020 Equine Prohibited Substances List
- Statistical Analysis Plan: 20140254 Date: 07 January 2017 Page 24
- Drug-Induced QT-Interval Prolongation and Proarrhythmic Risk
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- 62: Β-Adrenergic Antagonists
- Junctional Ectopic Tachycardia (JET) Care Guideline for Cardiovascular Intensive Care Unit (CVICU)
- Comparison Between Esmolol and Verapamil in Attenuation of Cardiovascular Stress Response to Laryngoscopy and Endotracheal Intubation in Elective Surgery
- Esmolol Compared with Amiodarone in the Treatment of Recent-Onset Atrial Fibrillation (Raf): an Emergency Medicine External Validity Study
- Drug Repositioning and Indication Discovery Using Description Logics
- Esmolol in Cardiology, Emergency and Critical-Care Medicine “Meet the Expert” Meeting – March 5Th, 2012, Vienna
- Summary of Product Characteristics
- (12) Patent Application Publication (10) Pub. No.: US 2009/0098207 A1 Malakhov Et Al
- Adrenergic Blockers in Regard to Their Stereochemistry
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Utility of Esmolol in Thyroid Crisis
- Proximal Pathway Enrichment Analysis for Targeting Comorbid Diseases Via Network Endopharmacology